Ludger Kolbe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ludger Kolbe has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Jan Batzer
Research & Development, Beiersdorf AG Hamburg Germany
4 shared publications- Shosuke Ito
Institute for Melanin Chemistry, Fujita Health University
4 shared publications - Tamara Rogers
Research and Development, Beiersdorf AG, 20245 Hamburg, Germany
4 shared publications Tobias Mann
R&D Discovery, Beiersdorf AG, Hamburg, Germany
4 shared publicationsFranz Stäb
Front End Innovation, Beiersdorf AG, Hamburg, Germany
3 shared publicationsHorst Wenck
Front End Innovation, Beiersdorf AG, Hamburg, Germany
3 shared publications
Latest Publications
- 24 February 2026
- Published by Springer Nature
- p. 127-151
Hyperpigmentation Agents
- Open Access
- 19 January 2026
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 25 (2) , 299-306
Visible light induces skin darkening in vivo: comparative pilot studies reveal enhanced susceptibility in melasma and its mitigation by a human tyrosinase inhibitor
Melasma is a common and recurring disorder of hyperpigmentation, characterized by dark spots that are distributed on sun-exposed areas of the skin. Whereas studies on sun-induced skin pigmentation have concentrated on implications of ultraviolet (UV) radiation, the effect of visible light (VIS) was long considered negligible. Optically opaque, tinted face care products have shown to prevent darkening of melasma spots, leading to the hypothesis that VIS plays a role in hyperpigmentation. Here, we analyzed the effects of VIS on melasma, and investigated how skin reacts to the exposure of UV and VIS irradiation, both separately and combined. Furthermore, we examined the impact of daily treatment with the tyrosinase inhibitor isobutylamido thiazolyl resorcinol (Thiamidol) on repetitive VIS irradiation. We show that melasma lesions respond more strongly to VIS than perilesional skin and were more conspicuous after irradiation. Also, in healthy skin, VIS alone induced immediate pigment darkening and delayed tanning. However, compared to vehicle treatment, the tyrosinase inhibitor Thiamidol significantly reduced the VIS-induced darkening in healthy skin. Graphical abstract
- 19 January 2026
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 25 (2) , 299-306
Open AccessVisible light induces skin darkening in vivo: comparative pilot studies reveal enhanced susceptibility in melasma and its mitigation by a human tyrosinase inhibitor
Melasma is a common and recurring disorder of hyperpigmentation, characterized by dark spots that are distributed on sun-exposed areas of the skin. Whereas studies on sun-induced skin pigmentation have concentrated on implications of ultraviolet (UV) radiation, the effect of visible light (VIS) was long considered negligible. Optically opaque, tinted face care products have shown to prevent darkening of melasma spots, leading to the hypothesis that VIS plays a role in hyperpigmentation. Here, we analyzed the effects of VIS on melasma, and investigated how skin reacts to the exposure of UV and VIS irradiation, both separately and combined. Furthermore, we examined the impact of daily treatment with the tyrosinase inhibitor isobutylamido thiazolyl resorcinol (Thiamidol) on repetitive VIS irradiation. We show that melasma lesions respond more strongly to VIS than perilesional skin and were more conspicuous after irradiation. Also, in healthy skin, VIS alone induced immediate pigment darkening and delayed tanning. However, compared to vehicle treatment, the tyrosinase inhibitor Thiamidol significantly reduced the VIS-induced darkening in healthy skin. Graphical abstract
- Open Access
- 22 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 97
Targeting Melanin Production: The Safety of Tyrosinase Inhibition
Hyperpigmentation remains a persistent dermatological challenge with limited treatment options. Among available strategies, tyrosinase inhibition stands out as the current most effective and safest approach for suppressing melanin synthesis. Thiamidol exemplifies a targeted tyrosinase inhibitor developed over a decade of research, guided by rigorous toxicological evaluation. Although it contains a resorcinol moiety, Thiamidol is not a resorcinol derivative and acts through a distinct thiazole 2-amino moiety. In addition to its targeted mode of action of tyrosinase inhibition rather than inactivation, assessments of cytotoxicity and genotoxicity distinguish it from cosmetic and pharmaceutical active ingredients that form highly reactive ortho- or para-quinones. With further exclusion for off-target effects based on pharma profiling and exposure modeling, Thiamidol’s rapid metabolism and absence of bioaccumulation support its safety profile. While an inhibitory mechanism requires repeated application, this characteristic enhances the safety profile and establishes Thiamidol as a cosmetic ingredient rather than a pharmaceutical. In additional to confirmatory clinical studies for efficacy and skin compatibility, a study shows that the use of Thiamidol-containing products does not negatively impact the dermatological diagnostic accessibility of naevi, which is important for skin health monitoring.
- 22 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 97
Open AccessTargeting Melanin Production: The Safety of Tyrosinase Inhibition
Hyperpigmentation remains a persistent dermatological challenge with limited treatment options. Among available strategies, tyrosinase inhibition stands out as the current most effective and safest approach for suppressing melanin synthesis. Thiamidol exemplifies a targeted tyrosinase inhibitor developed over a decade of research, guided by rigorous toxicological evaluation. Although it contains a resorcinol moiety, Thiamidol is not a resorcinol derivative and acts through a distinct thiazole 2-amino moiety. In addition to its targeted mode of action of tyrosinase inhibition rather than inactivation, assessments of cytotoxicity and genotoxicity distinguish it from cosmetic and pharmaceutical active ingredients that form highly reactive ortho- or para-quinones. With further exclusion for off-target effects based on pharma profiling and exposure modeling, Thiamidol’s rapid metabolism and absence of bioaccumulation support its safety profile. While an inhibitory mechanism requires repeated application, this characteristic enhances the safety profile and establishes Thiamidol as a cosmetic ingredient rather than a pharmaceutical. In additional to confirmatory clinical studies for efficacy and skin compatibility, a study shows that the use of Thiamidol-containing products does not negatively impact the dermatological diagnostic accessibility of naevi, which is important for skin health monitoring.
- Open Access
- 12 December 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (7) , 1837-1850.e4
Primary keratinocyte model of actinic keratosis reveals UV-induced DNA damage accumulation and persistent IFN signaling
- 12 December 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (7) , 1837-1850.e4
Open AccessPrimary keratinocyte model of actinic keratosis reveals UV-induced DNA damage accumulation and persistent IFN signaling
- Open Access
- 4 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10734
Mechanistic Insights into Tyrosinase-Catalyzed Metabolism of Hydroquinone: Implications for the Etiology of Exogenous Ochronosis and Cytotoxicity to Melanocytes
The metabolism of hydroquinone (HQ) by tyrosinase presents significant biochemical and dermatological challenges, particularly due to its association with adverse effects such as exogenous ochronosis (EO). Despite its widespread use in skin-lightening products, the detailed mechanistic pathways of HQ metabolism by tyrosinase remain inadequately understood. This study aims to elucidate the mechanistic insights into the tyrosinase-catalyzed metabolism of HQ, leading to the production of HQ-eumelanin (HQ-EM) and HQ-pheomelanin (HQ-PM). We employed HPLC analysis to detect key intermediates and final metabolites. Results show that mushroom tyrosinase catalyzes the hydroxylation of HQ to 2-hydroxyhydroquinone (HHQ) via the 2-hydroxybenzoquinone (HBQ) pathway, giving rise to HQ-EM. However, in the presence of cysteine, a shift from HBQ to the benzoquinone (BQ) pathway occurs, giving rise to HQ-PM. Hydroiodic acid hydrolysis of HQ-PM and subsequent HPLC-electrochemical analysis identified 4-aminophenol (AP) as degradation product, thereby serving as a novel marker to monitor HQ oxidation in vitro. These results indicate that HQ functions both as a “pseudo” substrate for tyrosinase—undergoing redox exchange with dopaquinone to form BQ—and as a true substrate, yielding HBQ. This dual role contributes to the formation of HQ-EM and HQ-PM. It would be possible that EO is caused by a continuous oxidation of HQ mediated by tyrosinase activity in the skin.
- 4 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10734
Open AccessMechanistic Insights into Tyrosinase-Catalyzed Metabolism of Hydroquinone: Implications for the Etiology of Exogenous Ochronosis and Cytotoxicity to Melanocytes
The metabolism of hydroquinone (HQ) by tyrosinase presents significant biochemical and dermatological challenges, particularly due to its association with adverse effects such as exogenous ochronosis (EO). Despite its widespread use in skin-lightening products, the detailed mechanistic pathways of HQ metabolism by tyrosinase remain inadequately understood. This study aims to elucidate the mechanistic insights into the tyrosinase-catalyzed metabolism of HQ, leading to the production of HQ-eumelanin (HQ-EM) and HQ-pheomelanin (HQ-PM). We employed HPLC analysis to detect key intermediates and final metabolites. Results show that mushroom tyrosinase catalyzes the hydroxylation of HQ to 2-hydroxyhydroquinone (HHQ) via the 2-hydroxybenzoquinone (HBQ) pathway, giving rise to HQ-EM. However, in the presence of cysteine, a shift from HBQ to the benzoquinone (BQ) pathway occurs, giving rise to HQ-PM. Hydroiodic acid hydrolysis of HQ-PM and subsequent HPLC-electrochemical analysis identified 4-aminophenol (AP) as degradation product, thereby serving as a novel marker to monitor HQ oxidation in vitro. These results indicate that HQ functions both as a “pseudo” substrate for tyrosinase—undergoing redox exchange with dopaquinone to form BQ—and as a true substrate, yielding HBQ. This dual role contributes to the formation of HQ-EM and HQ-PM. It would be possible that EO is caused by a continuous oxidation of HQ mediated by tyrosinase activity in the skin.
- Open Access
- 15 July 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (5) , 959-967
Exogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone
Background: Hydroquinone is widely used for its hypopigmenting effects in treating hyperpigmentation disorders. However, its topical application has been linked to adverse effects, notably exogenous ochronosis, raising concerns about its safety and mechanisms of action. Objectives: To elucidate the metabolic pathway of hydroquinone in human melanocytes and to clarify the role of tyrosinase in the development of exogenous ochronosis. Methods: We conducted an in vitro investigation using human tyrosinase to analyse the metabolism of hydroquinone. The study involved assessing the oxidation of hydroquinone in the presence of L-DOPA and L-cysteine, measuring the production of dopaquinone and its subsequent derivatives, including 2-S-cysteinyl–hydroquinone (Cys-HQ) and hydroquinone–pheomelanin (HQ-PM). Results: Our findings demonstrate that human tyrosinase effectively oxidizes hydroquinone primarily via dopaquinone, with L-cysteine facilitating the formation of Cys-HQ. Further oxidation of Cys-HQ leads to the production of HQ-PM. Notably, the results indicate that tyrosinase activity is crucial for the induction of exogenous ochronosis by hydroquinone. Additionally, while high-molecular-weight hydroquinone derivatives may remain within melanosomes, low-molecular-weight metabolites can penetrate the dermis, potentially triggering the polymerization of ochronotic particles similar to those seen in exogenous ochronosis. Conclusions: Tyrosinase plays a significant role in hydroquinone-induced exogenous ochronosis, suggesting that hydroquinone acts as a ‘pseudo’ substrate for this enzyme. The findings highlight the importance of using tyrosinase inhibitors to reduce the risk of exogenous ochronosis, while cautioning against other melanogenesis inhibitors that may have similar side effects.
- 15 July 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (5) , 959-967
Open AccessExogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone
Background: Hydroquinone is widely used for its hypopigmenting effects in treating hyperpigmentation disorders. However, its topical application has been linked to adverse effects, notably exogenous ochronosis, raising concerns about its safety and mechanisms of action. Objectives: To elucidate the metabolic pathway of hydroquinone in human melanocytes and to clarify the role of tyrosinase in the development of exogenous ochronosis. Methods: We conducted an in vitro investigation using human tyrosinase to analyse the metabolism of hydroquinone. The study involved assessing the oxidation of hydroquinone in the presence of L-DOPA and L-cysteine, measuring the production of dopaquinone and its subsequent derivatives, including 2-S-cysteinyl–hydroquinone (Cys-HQ) and hydroquinone–pheomelanin (HQ-PM). Results: Our findings demonstrate that human tyrosinase effectively oxidizes hydroquinone primarily via dopaquinone, with L-cysteine facilitating the formation of Cys-HQ. Further oxidation of Cys-HQ leads to the production of HQ-PM. Notably, the results indicate that tyrosinase activity is crucial for the induction of exogenous ochronosis by hydroquinone. Additionally, while high-molecular-weight hydroquinone derivatives may remain within melanosomes, low-molecular-weight metabolites can penetrate the dermis, potentially triggering the polymerization of ochronotic particles similar to those seen in exogenous ochronosis. Conclusions: Tyrosinase plays a significant role in hydroquinone-induced exogenous ochronosis, suggesting that hydroquinone acts as a ‘pseudo’ substrate for this enzyme. The findings highlight the importance of using tyrosinase inhibitors to reduce the risk of exogenous ochronosis, while cautioning against other melanogenesis inhibitors that may have similar side effects.
- 20 May 2025
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 47 (5) , 851-863
A new in vitro approach for determining the water resistance of sunscreen products, validated by a blinded ring test
Despite limited consumer understanding of sunscreen labelling, product choice remains primarily driven by the labelled Sun Protection Factor (SPF), alongside UVA protection and water resistance claims. To ensure the reliability of these key parameters, validated and reproducible testing methods are essential. In response to recent ISO publications on in vivo water resistance evaluation, the Cosmetics Europe Sun Protection Methods Task Force has initiated the development of a robust in vitro alternative. Current in vitro approaches are based on thin‐film UV transmittance techniques, but their accuracy is highly sensitive to film homogeneity, both during application and after immersion. It has been shown that immersion can induce film rearrangement, altering UV absorbance without necessarily reducing active ingredient content. This may lead to atypical results, including apparent increases in SPF values post‐immersion. Here, in a ring‐testing approach, we investigate a new method for determining the in vitro water resistance of sunscreen products. This study aims to identify the most robust and predictive in vitro alternative, contributing to the development of a standardized and scientifically reliable method for water resistance assessment in sunscreen products.
- 20 May 2025
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 47 (5) , 851-863
A new in vitro approach for determining the water resistance of sunscreen products, validated by a blinded ring test
Despite limited consumer understanding of sunscreen labelling, product choice remains primarily driven by the labelled Sun Protection Factor (SPF), alongside UVA protection and water resistance claims. To ensure the reliability of these key parameters, validated and reproducible testing methods are essential. In response to recent ISO publications on in vivo water resistance evaluation, the Cosmetics Europe Sun Protection Methods Task Force has initiated the development of a robust in vitro alternative. Current in vitro approaches are based on thin‐film UV transmittance techniques, but their accuracy is highly sensitive to film homogeneity, both during application and after immersion. It has been shown that immersion can induce film rearrangement, altering UV absorbance without necessarily reducing active ingredient content. This may lead to atypical results, including apparent increases in SPF values post‐immersion. Here, in a ring‐testing approach, we investigate a new method for determining the in vitro water resistance of sunscreen products. This study aims to identify the most robust and predictive in vitro alternative, contributing to the development of a standardized and scientifically reliable method for water resistance assessment in sunscreen products.
- Open Access
- 8 February 2021
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 43 (3) , 292-301
Effective reduction of post‐inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido‐thiazolyl‐resorcinol (Thiamidol)
Objective: Post‐inflammatory hyperpigmentation (PIH) is a major cosmetic concern especially in individuals with darker skin complexion. Unfortunately, treatment with anti‐inflammatory ingredients alone does not prevent the development of hyperpigmented spots. Recently, isobutylamido‐thiazolyl‐resorcinol (Thiamidol) was described as a very potent inhibitor of human tyrosinase. The objective of this research was to investigate the potential of this compound to prevent PIH induced by epidermal wounding (suction blister) and related to acne.Methods: Suction blister‐induced PIH was treated with a formulation containing Thiamidol or a vehicle for 3 months, and the changes in hyperpigmentation were monitored by spectroscopic measurements. The effect of skin care formulations containing Thiamidol on acne‐related PIH was investigated in two studies, a vehicle‐controlled, double‐blinded, randomized clinical study and a clinical observational study. Both studies had a duration of 3 months and included assessments such as clinical photography, clinical grading and melanin index measurements.Results: Already after 2 weeks of treatment, suction blister sites treated with Thiamidol were significantly lighter than control sites and improved throughout the treatment period. Subjects´ self‐grading demonstrated that Thiamidol significantly improved the visibility of acne‐induced hyperpigmentation compared to the vehicle treatment. A skin care regimen with Thiamidol significantly improved acne‐related PIH over 12 weeks shown by Mexameter measurements, expert grading, self‐grading and clinical photography.Conclusion: Thiamidol represents a safe and effective ingredient for cosmetic products against post‐inflammatory hyperpigmentation.
- 8 February 2021
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 43 (3) , 292-301
Open AccessEffective reduction of post‐inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido‐thiazolyl‐resorcinol (Thiamidol)
Objective: Post‐inflammatory hyperpigmentation (PIH) is a major cosmetic concern especially in individuals with darker skin complexion. Unfortunately, treatment with anti‐inflammatory ingredients alone does not prevent the development of hyperpigmented spots. Recently, isobutylamido‐thiazolyl‐resorcinol (Thiamidol) was described as a very potent inhibitor of human tyrosinase. The objective of this research was to investigate the potential of this compound to prevent PIH induced by epidermal wounding (suction blister) and related to acne.Methods: Suction blister‐induced PIH was treated with a formulation containing Thiamidol or a vehicle for 3 months, and the changes in hyperpigmentation were monitored by spectroscopic measurements. The effect of skin care formulations containing Thiamidol on acne‐related PIH was investigated in two studies, a vehicle‐controlled, double‐blinded, randomized clinical study and a clinical observational study. Both studies had a duration of 3 months and included assessments such as clinical photography, clinical grading and melanin index measurements.Results: Already after 2 weeks of treatment, suction blister sites treated with Thiamidol were significantly lighter than control sites and improved throughout the treatment period. Subjects´ self‐grading demonstrated that Thiamidol significantly improved the visibility of acne‐induced hyperpigmentation compared to the vehicle treatment. A skin care regimen with Thiamidol significantly improved acne‐related PIH over 12 weeks shown by Mexameter measurements, expert grading, self‐grading and clinical photography.Conclusion: Thiamidol represents a safe and effective ingredient for cosmetic products against post‐inflammatory hyperpigmentation.
- Open Access
- 31 July 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Concomitant DNA methylation and transcriptome signatures define epidermal responses to acute solar UV radiation
The simultaneous analysis of different regulatory levels of biological phenomena by means of multi-omics data integration has proven an invaluable tool in modern precision medicine, yet many processes ultimately paving the way towards disease manifestation remain elusive and have not been studied in this regard. Here we investigated the early molecular events following repetitive UV irradiation of in vivo healthy human skin in depth on transcriptomic and epigenetic level. Our results provide first hints towards an immediate acquisition of epigenetic memories related to aging and cancer and demonstrate significantly correlated epigenetic and transcriptomic responses to irradiation stress. The data allowed the precise prediction of inter-individual UV sensitivity, and molecular subtyping on the integrated post-irradiation multi-omics data established the existence of three latent molecular phototypes. Importantly, further analysis suggested a form of melanin-independent DNA damage protection in subjects with higher innate UV resilience. This work establishes a high-resolution molecular landscape of the acute epidermal UV response and demonstrates the potential of integrative analyses to untangle complex and heterogeneous biological responses.
- 31 July 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Open AccessConcomitant DNA methylation and transcriptome signatures define epidermal responses to acute solar UV radiation
The simultaneous analysis of different regulatory levels of biological phenomena by means of multi-omics data integration has proven an invaluable tool in modern precision medicine, yet many processes ultimately paving the way towards disease manifestation remain elusive and have not been studied in this regard. Here we investigated the early molecular events following repetitive UV irradiation of in vivo healthy human skin in depth on transcriptomic and epigenetic level. Our results provide first hints towards an immediate acquisition of epigenetic memories related to aging and cancer and demonstrate significantly correlated epigenetic and transcriptomic responses to irradiation stress. The data allowed the precise prediction of inter-individual UV sensitivity, and molecular subtyping on the integrated post-irradiation multi-omics data established the existence of three latent molecular phototypes. Importantly, further analysis suggested a form of melanin-independent DNA damage protection in subjects with higher innate UV resilience. This work establishes a high-resolution molecular landscape of the acute epidermal UV response and demonstrates the potential of integrative analyses to untangle complex and heterogeneous biological responses.
- Open Access
- 10 May 2020
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 42 (5) , 421-428
Validation of a new in vitro Sun Protection Factor method to include a wide range of sunscreen product emulsion types
In 2017, Cosmetics Europe performed a double‐blinded ring test of 24 emulsion‐type sunscreen products, across 3 in vivo test laboratories and 3 in vitro test laboratories, using a new candidate in vitro SPF test method. Based on the results of this work, an article was published showing how data derived from a new lead candidate method conform to new International Standards (ISO) acceptance criteria for alternative SPF test methods (Any alternative method should consider the matrix effect and if required, specify the matrix applicability of the method; Criterion 1a: Systematic differences between methods should be negligible: 95% of all individual results of an alternative method are within the range of ±2× reproducibility standard deviation of the in vivo method, that is overall bias must be below 0.5× reproducibility standard deviation of the in vivo method; Criterion 1b: Measurement uncertainty of an alternative method should be below the measurement uncertainty of the in vivo method. Candidate method predicted values must fall within the full ‘funnel’ (SPF 6‐50+) limits proposed by Cosmetics Europe (derived from the same minimum test design, that is using the ISO24444 Method to measure at least 24 products across at least 3 laboratories using at least 5 test subjects/laboratory, in a blinded fashion).). Of the 24 sunscreen products tested, the majority of emulsions were of the oil‐in‐water (O/W) type, whereas only one was water‐in‐oil (W/O) and there were no products with a mineral‐only sun filter system. In order to confirm the scope of this method, therefore, a new study was conducted that included 73 W/O (12 mineral + organic, 44 mineral only and 17 organic only) and 3 O/W mineral‐only, emulsion‐type sunscreen products (a total of 76 new sunscreen products). When combined with the previous 24 products (tested in 3 different laboratories), this yielded a new data set comprising a total of 100 emulsion‐type sunscreen products, with SPF values ranging from 6 to 50+ (with a total of 148 data points). These products were tested using the double‐plate in vitro SPF test method and compared with the ISO TC217/WG7 acceptance criteria for alternative SPF test methods. Over 95% of paired in vitro: in vivo SPF values lay within the upper and lower limits of the ISO acceptance criteria funnel, with no bias. This new in vitro SPF test method, therefore, meets the minimum requirements for an alternative SPF test method to ISO24444:2010, for emulsion‐type sunscreen products (which make up the majority of marketed sunscreen products).
- 10 May 2020
- Published by Wiley in International Journal of Cosmetic Science
- Vol. 42 (5) , 421-428
Open AccessValidation of a new in vitro Sun Protection Factor method to include a wide range of sunscreen product emulsion types
In 2017, Cosmetics Europe performed a double‐blinded ring test of 24 emulsion‐type sunscreen products, across 3 in vivo test laboratories and 3 in vitro test laboratories, using a new candidate in vitro SPF test method. Based on the results of this work, an article was published showing how data derived from a new lead candidate method conform to new International Standards (ISO) acceptance criteria for alternative SPF test methods (Any alternative method should consider the matrix effect and if required, specify the matrix applicability of the method; Criterion 1a: Systematic differences between methods should be negligible: 95% of all individual results of an alternative method are within the range of ±2× reproducibility standard deviation of the in vivo method, that is overall bias must be below 0.5× reproducibility standard deviation of the in vivo method; Criterion 1b: Measurement uncertainty of an alternative method should be below the measurement uncertainty of the in vivo method. Candidate method predicted values must fall within the full ‘funnel’ (SPF 6‐50+) limits proposed by Cosmetics Europe (derived from the same minimum test design, that is using the ISO24444 Method to measure at least 24 products across at least 3 laboratories using at least 5 test subjects/laboratory, in a blinded fashion).). Of the 24 sunscreen products tested, the majority of emulsions were of the oil‐in‐water (O/W) type, whereas only one was water‐in‐oil (W/O) and there were no products with a mineral‐only sun filter system. In order to confirm the scope of this method, therefore, a new study was conducted that included 73 W/O (12 mineral + organic, 44 mineral only and 17 organic only) and 3 O/W mineral‐only, emulsion‐type sunscreen products (a total of 76 new sunscreen products). When combined with the previous 24 products (tested in 3 different laboratories), this yielded a new data set comprising a total of 100 emulsion‐type sunscreen products, with SPF values ranging from 6 to 50+ (with a total of 148 data points). These products were tested using the double‐plate in vitro SPF test method and compared with the ISO TC217/WG7 acceptance criteria for alternative SPF test methods. Over 95% of paired in vitro: in vivo SPF values lay within the upper and lower limits of the ISO acceptance criteria funnel, with no bias. This new in vitro SPF test method, therefore, meets the minimum requirements for an alternative SPF test method to ISO24444:2010, for emulsion‐type sunscreen products (which make up the majority of marketed sunscreen products).